Cargando…
Mammary epithelial cell phenotype disruption in vitro and in vivo through ERalpha36 overexpression
Estrogen receptor alpha 36 (ERα36) is a variant of the canonical estrogen receptor alpha (ERα66), widely expressed in hormone sensitive cancer cells and whose high expression level correlates with a poor survival prognosis for breast cancer patients. While ERα36 activity have been related to breast...
Autores principales: | Thiebaut, Charlène, Chamard-Jovenin, Clémence, Chesnel, Amand, Morel, Chloé, Djermoune, El-Hadi, Boukhobza, Taha, Dumond, Hélène |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354400/ https://www.ncbi.nlm.nih.gov/pubmed/28301550 http://dx.doi.org/10.1371/journal.pone.0173931 |
Ejemplares similares
-
Low-Dose Alkylphenol Exposure Promotes Mammary Epithelium Alterations and Transgenerational Developmental Defects, But Does Not Enhance Tumorigenic Behavior of Breast Cancer Cells
por: Chamard-Jovenin, Clémence, et al.
Publicado: (2017) -
From ERα66 to ERα36: a generic method for validating a prognosis marker of breast tumor progression
por: Chamard-Jovenin, Clémence, et al.
Publicado: (2015) -
An Alkylphenol Mix Promotes Seminoma Derived Cell Proliferation through an ERalpha36-Mediated Mechanism
por: Ajj, Hussein, et al.
Publicado: (2013) -
Dual Epigenetic Regulation of ERα36 Expression in Breast Cancer Cells
por: Thiebaut, Charlène, et al.
Publicado: (2019) -
The Role of ERα36 in Development and Tumor Malignancy
por: Thiebaut, Charlène, et al.
Publicado: (2020)